Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

C.-Y. Peng; H.-C. Lai; Y.-F. Li; W.-P. Su; P.-H. Chuang; J.-T. Kao

首页> 外文期刊>Alimentary Pharmacology & Therapeutics >Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

【24h】

Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

机译：早期血清HBsAg水平是HBeAg阴性慢性乙型肝炎对peginterferon alfa-2a持续响应的有力预测指标

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The roles remain unclear of early on-treatment quantitative serum HBsAg and hepatitis B virus (HBV) DNA levels in the prediction of a sustained response (SR) to peginterferon alfa-2a therapy in HBeAg-negative chronic hepatitis B (CHB) patients infected with genotype B or C.

机译：早期治疗中定量的血清HBsAg和乙型肝炎病毒（HBV）DNA水平在预测感染了HBeAg阴性的慢性乙型肝炎（CHB）患者对聚乙二醇干扰素alfa-2a治疗的持续反应（SR）中的作用尚不清楚基因型B或C。

著录项

来源
《Alimentary Pharmacology & Therapeutics》 |2012年第4期|458-468|共11页
作者
C.-Y. Peng; H.-C. Lai; Y.-F. Li; W.-P. Su; P.-H. Chuang; J.-T. Kao;
展开▼
作者单位

School of Medicine China Medical University Taichung Taiwan;

College of Chinese Medicine China Medical University Taichung Taiwan;

Division of Hepatogastroenterology Department of Internal Medicine China Medical University Hospital Taichung Taiwan;

Department of Public Health and Biostatistics Center China Medical University Taichung Taiwan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B [J] . C.-Y. Peng, H.-C. Lai, Y.-F. Li, Alimentary pharmacology & therapeutics. . 2012,第4期

机译：早期血清HBsAg水平是HBeAg阴性慢性乙型肝炎对聚乙二醇干扰素α-2a持续应答的有力预测指标
2. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels. [J] . Rijckborst V, Hansen BE, Cakaloglu Y, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2010,第2期

机译：使用HBsAg和HBV DNA水平，可早期预测对聚乙二醇干扰素α-2a的HBeAg阴性慢性乙型肝炎的反应。
3. Commentary: HBsAg levels as predictor of sustained response to peginterferon in HBeAg-negative chronic hepatitis B - Author's reply [J] . PengC.-Y. Alimentary pharmacology & therapeutics. . 2012,第7期

机译：评论：HBsAg水平可预测HBeAg阴性慢性乙型肝炎对聚乙二醇干扰素的持续反应-作者的回复
4. HCV-related Factors but not HIV-Related Factors at Baseline Predict the Response to Treatment With Peginterferon alfa-2a (40KD) (PEGASYS) Plus Ribavirin (COPEGUS) in Patients With HCV/HIV Co-infection: Predictor Analysis From the APRICOT Study [C] . D. Cooper, F.J. Torriani, M. Rodriguez Torres International AIDS Conference . 2004

机译：HCV相关因素但基线上没有艾滋病毒相关因素预测与HCV / HIV共感染患者的Peginterferon Alfa-2a（40kd）（Pegasys）（Pegasys）加利巴韦林（Copegus）对治疗的反应：来自杏研究的预测因素分析
5. Assessment of health-related quality of life in adult chronic hepatitis C patients with different categories of disease and sustained response to Intron(rtm) A. [D] . Martino, Frances P. 1997

机译：评估患有不同疾病类别并持续对Intron（rtm）A做出反应的成人慢性丙型肝炎患者的健康相关生活质量。
6. Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B [O] . Teerha Piratvisuth, George Lau, You-Chen Chao, 2008

机译：有HBeAg阳性和HBeAg阴性的慢性乙型肝炎患者对有或无拉米夫定的聚乙二醇干扰素alfa-2a（40kD）的持续反应
7. Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels [O] . Vincent Rijckborst, Bettina E. Hansen, Yilmaz Cakaloglu, 2010

机译：利用HBsAg和HBV DNA水平，对HBeAg阴性慢性乙型肝炎的Peginterferon Alfa-2a的早期治疗预测

Early serum HBsAg level as a strong predictor of sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

摘要

著录项

相似文献

相关主题

期刊订阅